Monograph
J01XX05 - Methenamine |
Not porphyrinogenic |
NP |
Rationale
Water-soluble organic salt. Two references consider it safe. Several observations of non-porphyrinogenicity.
Chemical description
Metenamine hippurate, Largely excreted unchanged but hydrolyzed in the urinay tract to formaldehyde and ammonia, excreted in urine. Previously often in use in acute porphyrias as an antibacterial agent in urinary tract infections. Probably without CYP affinity. South African list: use. Metabolic Basis…ref 279: probably safe. Thunell: On many occasions observed to be tolerated.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Xcyst · Xcyst 500 mg, maagsapresistente tablettenUnited Kingdom
Hiprex · Hiprex 1g tablets · Methenamine hippurate · Methenamine hippurate 1g tabletsDenmark
Haiprex · Methenamine hippurate · Methenamine hippurate "EQL Pharma"Norway
Hiprex · Methenamine hippurate EQL PharmaIceland
HaiprexFinland
Hiprex · Methenamine hippurate Orion
© NAPOS 2024